data_2a29_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2a29 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . 0.451 ' HB2' HG12 ' A' ' 448' ' ' ILE . 84.3 m-20 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.273 0.559 . . . . 3.02 110.18 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -123.34 136.76 54.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.91 . . . . 2.8700000000000001 110.301 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.45 ' HA ' ' HB3' ' A' ' 351' ' ' SER . 53.2 tt0 -138.82 140.31 38.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.373 -0.83 . . . . 3.23 110.334 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.526 ' HB3' ' CD2' ' A' ' 355' ' ' LEU . . . -64.72 131.79 47.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.961 -1.087 . . . . 1.04 109.838 175.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.463 ' O ' HD11 ' A' ' 355' ' ' LEU . 1.8 m -110.78 -39.15 4.93 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.172 -0.955 . . . . 0.93999999999999995 110.333 175.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.454 ' HG2' HD12 ' A' ' 323' ' ' ILE . 82.9 tt0 -145.13 144.76 31.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.108 -0.995 . . . . 1.45 110.938 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.579 ' CE2' ' HB1' ' A' ' 334' ' ' ALA . 34.1 p90 -117.49 146.87 43.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.212 -0.93 . . . . 1.21 110.3 173.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.474 ' O ' HD22 ' A' ' 333' ' ' LEU . 10.5 mm -127.74 137.89 31.7 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.27 -0.894 . . . . 1.99 110.392 174.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.534 ' CB ' ' O ' ' A' ' 328' ' ' VAL . 13.0 Cg_exo -62.92 156.5 53.86 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.089 1.573 . . . . 0.34999999999999998 111.112 -178.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.553 ' CB ' ' CG2' ' A' ' 416' ' ' VAL . . . -77.18 -166.13 0.67 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.42 -0.8 . . . . 1.05 109.663 172.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.458 ' HG3' ' OD2' ' A' ' 415' ' ' ASP . 57.1 tt0 -63.84 104.22 0.66 Allowed 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.279 -0.888 . . . . 0.87 110.387 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 92.64 15.71 51.76 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.389 -1.084 . . . . 0.22 110.389 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 57.1 t -104.08 151.28 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.949 -1.324 . . . . 1.01 110.693 -177.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -90.06 144.3 26.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.239 -0.913 . . . . 1.8100000000000001 110.309 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.528 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.2 pt-20 -65.08 -39.76 93.68 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.244 -0.91 . . . . 1.9099999999999999 110.642 -176.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . 0.578 ' HA ' ' CZ ' ' A' ' 360' ' ' PHE . 86.9 tttt -60.86 -44.66 96.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.007 -1.058 . . . . 2.8999999999999999 110.278 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 89.1 m -59.03 -45.74 89.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.129 -0.982 . . . . 1.1000000000000001 110.309 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.529 ' CD1' HD11 ' A' ' 440' ' ' LEU . 20.4 tp -59.99 -45.3 93.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.215 -0.928 . . . . 1.1899999999999999 111.172 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.579 ' HB1' ' CE2' ' A' ' 322' ' ' PHE . . . -61.31 -39.24 89.77 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.142 -0.974 . . . . 1.0600000000000001 109.9 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.508 ' OD2' ' NH2' ' A' ' 365' ' ' ARG . 57.5 t0 -65.2 -45.55 84.32 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.053 -1.029 . . . . 1.47 111.337 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.487 ' HA ' HD23 ' A' ' 339' ' ' LEU . . . -65.43 -37.04 85.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.142 -0.974 . . . . 1.0600000000000001 110.309 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.467 ' HB3' ' NE2' ' A' ' 338' ' ' GLN . . . -64.21 -33.71 76.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.055 -1.028 . . . . 1.05 110.1 178.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.6 ' CG ' ' CB ' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -69.63 -52.82 22.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.885 . . . . 1.3100000000000001 111.361 -178.511 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.538 ' CD1' HG13 ' A' ' 393' ' ' ILE . 0.6 OUTLIER -70.08 -36.08 74.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.69 -1.256 . . . . 1.1100000000000001 110.478 -176.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.525 ' CB ' HG22 ' A' ' 393' ' ' ILE . . . -67.44 -13.69 62.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.013 -1.055 . . . . 1.1000000000000001 110.309 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.522 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 84.1 p -96.99 -16.57 20.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.27 -0.894 . . . . 0.88 110.271 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 338' ' ' GLN . 52.4 mt -58.69 -27.56 64.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.084 -1.01 . . . . 1.05 110.023 177.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.531 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.78 -20.98 25.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.3 -0.875 . . . . 1.02 110.892 -177.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.479 ' CB ' ' HB2' ' A' ' 377' ' ' PHE . 1.2 p30 -78.2 138.75 38.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.935 -1.103 . . . . 1.22 110.14 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -95.6 6.66 48.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.25 -0.906 . . . . 1.96 110.231 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' THR . . . . . 0.626 ' CG2' ' CD2' ' A' ' 377' ' ' PHE . 58.6 p -77.6 141.51 65.07 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.294 -0.879 . . . . 1.24 110.104 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -57.24 -34.99 98.82 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.991 1.522 . . . . 0.92000000000000004 110.233 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.504 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 97.2 mt-10 -64.1 -36.01 82.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.916 . . . . 1.4099999999999999 110.121 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.462 ' O ' HG21 ' A' ' 353' ' ' VAL . . . -58.08 -28.69 61.47 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.587 -1.405 . . . . 0.26000000000000001 109.587 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -75.39 -36.02 60.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.896 -1.355 . . . . 3.25 109.438 172.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 348' ' ' GLU . 17.8 m -54.62 -45.4 73.7 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.293 -0.879 . . . . 1.72 109.861 177.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.463 ' O ' ' OE1' ' A' ' 338' ' ' GLN . 10.4 mt -66.86 -47.16 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.061 -1.025 . . . . 1.0800000000000001 110.863 177.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.522 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 73.6 t -54.28 -31.42 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 120.733 -1.229 . . . . 1.1200000000000001 110.043 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.453 ' O ' ' HB3' ' A' ' 357' ' ' LYS . 54.5 mt -68.49 -45.81 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.872 -1.143 . . . . 1.0700000000000001 110.396 169.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.526 ' CD2' ' HB3' ' A' ' 319' ' ' ALA . 63.7 tp -47.26 -53.4 13.48 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.221 -0.924 . . . . 1.9099999999999999 110.394 -174.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.6 ' CB ' ' CG ' ' A' ' 338' ' ' GLN . . . -65.19 -36.6 84.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.797 -1.189 . . . . 1.0800000000000001 109.695 175.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 361' ' ' ASN . 7.8 tptp -53.76 -55.03 29.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.866 -1.146 . . . . 2.96 110.709 -176.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 14.1 pt20 -66.82 -40.65 88.08 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.585 -1.322 . . . . 1.47 109.866 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.45 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 39.7 mmt180 -70.67 -39.81 73.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.35 -0.844 . . . . 2.9300000000000002 111.485 -177.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.578 ' CZ ' ' HA ' ' A' ' 331' ' ' LYS . 99.4 m-85 -116.0 -14.76 11.22 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.791 -1.193 . . . . 1.3999999999999999 110.325 -176.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.535 ' N ' ' O ' ' A' ' 357' ' ' LYS . 44.9 t30 60.39 50.13 6.32 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.764 0.793 . . . . 1.6499999999999999 110.168 -177.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.545 ' CD1' ' CB ' ' A' ' 360' ' ' PHE . 23.2 mt -109.82 176.74 4.95 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.776 -0.578 . . . . 2.8799999999999999 109.815 -177.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -120.84 156.88 31.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.904 -1.122 . . . . 4.8499999999999996 110.967 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.465 ' HG2' HG12 ' A' ' 353' ' ' VAL . 95.5 mt-10 -55.52 149.8 13.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.6 -0.687 . . . . 2.2799999999999998 109.729 176.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.508 ' NH2' ' OD2' ' A' ' 335' ' ' ASP . 89.2 mtt180 -98.49 132.85 43.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.034 -1.041 . . . . 3.4500000000000002 110.18 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.461 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.3 m-20 -72.76 114.43 10.88 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.377 -0.827 . . . . 1.8600000000000001 109.908 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.64 ' CG2' ' CE1' ' A' ' 374' ' ' PHE . 55.6 t -70.56 -44.36 76.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.434 -0.792 . . . . 1.0600000000000001 110.593 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -74.49 -19.2 60.46 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.05 -1.031 . . . . 1.45 111.093 -176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.461 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 60.6 p -74.85 -24.7 58.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.773 -1.204 . . . . 1.75 109.143 171.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.524 ' CD1' HD11 ' A' ' 388' ' ' ILE . 44.3 mt -91.61 3.97 53.77 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.351 -0.843 . . . . 1.21 109.631 171.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 81.6 m-70 58.17 27.92 15.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.061 -1.025 . . . . 2.8399999999999999 108.746 -171.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.516 ' CB ' HG11 ' A' ' 367' ' ' VAL . . . -89.07 -167.12 1.78 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.474 0.654 . . . . 1.03 110.308 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' THR . . . . . 0.459 ' N ' ' CG1' ' A' ' 367' ' ' VAL . 41.5 m -139.68 143.69 37.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.58 -0.7 . . . . 1.1000000000000001 110.51 -177.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.64 ' CE1' ' CG2' ' A' ' 367' ' ' VAL . 73.4 m-85 -89.08 142.73 27.38 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.981 -1.074 . . . . 0.23999999999999999 109.596 172.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.565 ' CG1' ' NH1' ' A' ' 394' ' ' ARG . 20.5 t -108.63 112.74 60.46 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.874 -1.141 . . . . 1.03 109.835 174.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -54.38 151.6 29.19 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 124.101 1.579 . . . . 0.20999999999999999 111.378 -175.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.626 ' CD2' ' CG2' ' A' ' 346' ' ' THR . 1.0 OUTLIER -99.84 122.48 42.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.612 -0.68 . . . . 0.25 109.889 178.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 27.3 p -109.96 140.28 44.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 1.05 109.846 176.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.547 ' CB ' ' O2A' ' A' 1001 ' ' ANP . . . -75.85 -30.86 59.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.579 -0.7 . . . . 1.0700000000000001 110.539 -178.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -58.2 -44.55 88.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.147 -0.97 . . . . 0.71999999999999997 110.018 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 382' ' ' ARG . 66.7 m -90.81 -20.32 22.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.195 -0.941 . . . . 1.6399999999999999 109.786 173.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.517 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 68.6 mtt180 64.82 53.64 1.45 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.558 -0.714 . . . . 3.3399999999999999 109.526 -176.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.532 ' CG ' ' HB2' ' A' ' 400' ' ' ALA . 87.5 mtp -149.76 144.64 26.17 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.055 -1.028 . . . . 1.8999999999999999 111.299 -176.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.541 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 38.6 p -146.91 170.05 17.87 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.937 -1.135 . . . . 0.81999999999999995 107.937 172.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.436 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -175.74 -165.61 31.97 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 118.652 -1.737 . . . . 0.16 110.31 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.54 ' CG2' ' HB ' ' A' ' 393' ' ' ILE . 3.1 tt -151.43 149.92 13.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 O-C-N 121.892 -0.769 . . . . 1.0700000000000001 109.136 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . 0.446 ' HB2' ' HB ' ' A' ' 373' ' ' THR . 3.0 m120 -121.46 144.32 48.75 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.137 -0.977 . . . . 0.37 108.691 176.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.526 ' CG2' ' HB2' ' A' ' 391' ' ' ARG . 5.5 tt -144.81 164.78 12.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 O-C-N 120.693 -1.255 . . . . 1.29 110.165 176.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.73 7.83 0.1 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 113.467 0.914 . . . . 1.1599999999999999 113.467 -172.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.516 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 23.0 t-20 -144.85 2.73 1.05 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.141 -1.599 . . . . 1.5700000000000001 111.366 174.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.526 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 62.9 mtt85 -157.36 159.78 37.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.56 -1.337 . . . . 3.3500000000000001 110.957 -173.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 86.4 mtp -129.89 140.68 50.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.976 -1.077 . . . . 2.4199999999999999 109.074 167.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.54 ' HB ' ' CG2' ' A' ' 386' ' ' ILE . 15.4 mm -130.58 140.93 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.784 -1.198 . . . . 1.0700000000000001 110.148 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.565 ' NH1' ' CG1' ' A' ' 375' ' ' VAL . 28.5 mmt180 -140.9 141.74 34.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.896 . . . . 2.4500000000000002 110.452 175.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.557 ' HE3' ' N1 ' ' A' 1001 ' ' ANP . 0.1 OUTLIER -143.12 144.48 32.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.405 -0.81 . . . . 1.01 109.372 177.507 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.494 ' N ' HD13 ' A' ' 401' ' ' ILE . . . -179.25 -157.15 19.12 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.357 -1.402 . . . . 0.17999999999999999 110.223 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' SER . . . . . 0.517 ' OG ' ' CB ' ' A' ' 382' ' ' ARG . 28.4 m -69.54 155.47 40.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.358 -1.083 . . . . 1.6200000000000001 110.383 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.568 ' CG2' ' CG1' ' A' ' 420' ' ' VAL . 87.3 t -59.05 -47.13 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.155 -0.965 . . . . 1.1200000000000001 109.835 -177.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 90.4 m-20 -60.85 -38.7 86.43 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.946 -1.096 . . . . 1.6899999999999999 109.135 172.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.532 ' HB2' ' CG ' ' A' ' 383' ' ' MET . . . -61.11 -49.73 76.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.492 -0.755 . . . . 1.04 110.569 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.582 ' CG2' ' CG1' ' A' ' 434' ' ' VAL . 21.2 mm -66.35 -38.76 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.848 -1.158 . . . . 1.05 111.048 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -58.41 -41.94 86.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.862 -1.149 . . . . 2.71 110.106 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 48.9 mtm180 -66.83 -37.65 84.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.07 -1.019 . . . . 4.5300000000000002 110.847 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.517 ' NE2' ' HG3' ' A' ' 394' ' ' ARG . 86.6 t60 -64.17 -40.26 95.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.999 -1.063 . . . . 2.0699999999999998 110.728 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.52 HG13 ' CA ' ' A' ' 410' ' ' GLY . 97.6 t -64.87 -45.67 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.918 -1.114 . . . . 1.04 110.359 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -62.3 -35.07 77.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.865 -1.147 . . . . 1.4199999999999999 110.839 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.45 -42.22 87.92 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.048 -1.032 . . . . 1.04 109.754 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.467 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 98.2 m-20 -67.27 -24.97 65.85 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.374 -0.829 . . . . 1.8899999999999999 109.225 172.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.23 22.89 18.41 Favored Glycine 0 N--CA 1.483 1.776 0 N-CA-C 109.384 -1.486 . . . . 0.28000000000000003 109.384 -176.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.52 ' CA ' HG13 ' A' ' 405' ' ' VAL . . . -92.19 -171.17 41.41 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.458 -1.457 . . . . 0.22 109.458 177.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . 0.459 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 84.8 t60 -140.29 151.15 44.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.149 -1.206 . . . . 3.8599999999999999 110.205 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.487 ' CZ ' HG13 ' A' ' 432' ' ' VAL . 3.0 t80 -92.02 109.99 41.02 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.20999999999999999 110.078 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 24.7 Cg_exo -58.51 143.43 98.07 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.87 1.458 . . . . 0.19 110.802 -176.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.544 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.4 t -58.95 -43.85 91.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.309 -0.869 . . . . 1.05 110.497 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.544 ' N ' ' CG2' ' A' ' 414' ' ' THR . 92.3 m-20 -56.96 -40.37 76.34 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.086 -1.009 . . . . 1.6200000000000001 110.136 -177.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.553 ' CG2' ' CB ' ' A' ' 325' ' ' ALA . 53.7 t -68.54 -41.07 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.945 -1.097 . . . . 1.0700000000000001 110.687 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -62.39 -37.7 86.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.965 -1.084 . . . . 2.0 109.987 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.469 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 95.8 mt-30 -64.46 -42.38 95.97 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.202 -0.936 . . . . 3.0699999999999998 110.696 175.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.534 ' O ' ' CG2' ' A' ' 423' ' ' VAL . 46.3 mttp -63.56 -37.19 86.38 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.745 -1.222 . . . . 1.77 110.79 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.568 ' CG1' ' CG2' ' A' ' 398' ' ' VAL . 24.0 t -63.78 -42.01 94.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.073 -1.017 . . . . 1.0800000000000001 110.303 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 91.9 m-20 -70.46 -42.63 71.21 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.693 -0.629 . . . . 1.1000000000000001 110.863 -177.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.475 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 92.0 mt-30 -65.1 -31.1 72.14 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.337 -0.852 . . . . 2.5699999999999998 109.691 177.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 419' ' ' LYS . 75.3 t -60.62 -43.91 95.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.094 -1.004 . . . . 1.0600000000000001 109.764 172.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -69.99 -48.76 56.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.372 -0.83 . . . . 1.1000000000000001 110.197 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 83.5 mtp180 -54.56 -22.51 13.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 3.2200000000000002 109.77 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.0 mt-30 -90.31 3.39 53.79 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.384 -0.822 . . . . 2.6600000000000001 110.661 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 86.46 11.94 70.79 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.802 -1.319 . . . . 0.31 109.802 175.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.476 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.08 159.36 15.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -1.149 . . . . 1.0600000000000001 109.908 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.1 m -93.21 109.83 42.47 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.884 . . . . 1.04 108.853 173.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.489 ' HB2' HG12 ' A' ' 420' ' ' VAL . 3.9 Cg_exo -77.91 112.31 3.25 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 124.042 1.549 . . . . 0.20999999999999999 110.263 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.577 ' CD2' " O2'" ' A' 1001 ' ' ANP . 73.5 mt -90.07 161.78 15.64 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.812 -1.18 . . . . 1.45 108.317 165.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.516 ' CG1' HG13 ' A' ' 439' ' ' VAL . 68.0 t -124.84 138.14 55.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 120.751 -1.218 . . . . 1.03 110.187 175.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.461 HG11 HD21 ' A' ' 440' ' ' LEU . 22.3 t -117.06 138.05 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.708 -0.62 . . . . 1.0700000000000001 109.637 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.582 ' CG1' ' CG2' ' A' ' 401' ' ' ILE . 2.8 m -127.61 162.71 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.606 -0.684 . . . . 1.0700000000000001 109.981 178.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.53 ' HG2' ' CD1' ' A' ' 393' ' ' ILE . 7.8 mt-10 -116.37 123.93 48.8 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.058 -1.026 . . . . 1.23 108.879 166.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.79 -109.86 3.14 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 108.927 -1.669 . . . . 0.39000000000000001 108.927 -171.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 408' ' ' ASN . 25.9 p -119.84 11.16 11.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -1.141 . . . . 0.88 110.95 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . 0.494 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 30.1 ptt180 -119.71 142.16 48.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.917 -1.114 . . . . 2.8399999999999999 110.164 -177.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.516 HG13 ' CG1' ' A' ' 432' ' ' VAL . 46.0 t -78.93 127.08 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.406 -0.809 . . . . 1.0900000000000001 110.672 -177.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.529 HD11 ' CD1' ' A' ' 333' ' ' LEU . 0.7 OUTLIER -89.55 -26.06 21.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 1.21 110.718 178.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.519 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . -178.8 177.62 48.51 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 119.153 -1.499 . . . . 0.17000000000000001 110.899 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.527 HG11 ' CG2' ' A' ' 420' ' ' VAL . 72.2 t -121.42 150.33 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.522 -0.987 . . . . 1.02 109.782 178.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.527 HD13 ' CB ' ' A' ' 322' ' ' PHE . 11.9 mm -120.89 128.11 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.034 -1.042 . . . . 1.1100000000000001 110.851 -176.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.459 ' HA ' HG12 ' A' ' 423' ' ' VAL . . . -100.35 121.64 41.82 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.336 -0.853 . . . . 1.03 110.166 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.579 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 5.6 mp -101.25 136.76 40.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.075 -1.016 . . . . 1.1000000000000001 110.354 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -85.62 148.07 26.09 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.363 -0.836 . . . . 2.3799999999999999 109.617 172.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 447' ' ' ASP . 34.6 p30 -90.53 121.46 32.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 1.6699999999999999 110.494 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.583 ' N ' ' CD1' ' A' ' 448' ' ' ILE . 1.1 mp -52.75 -48.08 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 1.54 109.597 177.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.3 t -100.92 134.73 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.504 -0.747 . . . . 1.8999999999999999 110.217 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -145.02 130.66 18.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.261 -0.9 . . . . 3.9399999999999999 110.134 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.494 -1.442 . . . . 2.52 109.494 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1001 ' ' ANP . . . . . 0.592 ' C5 ' ' CE2' ' A' ' 377' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ASN . . . . . 0.462 ' HB2' HG12 ' A' ' 448' ' ' ILE . 84.3 m-20 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.273 0.559 . . . . 2.3900000000000001 110.18 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -123.34 136.76 54.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.91 . . . . 2.3199999999999998 110.301 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.468 ' HA ' ' HB3' ' A' ' 351' ' ' SER . 53.2 tt0 -138.82 140.31 38.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.373 -0.83 . . . . 2.6000000000000001 110.334 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 1.109 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -64.72 131.79 47.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.961 -1.087 . . . . 0.31 109.838 175.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.418 ' O ' HD11 ' A' ' 355' ' ' LEU . 1.8 m -110.78 -39.15 4.93 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.172 -0.955 . . . . 0.37 110.333 175.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.461 ' OE2' HD11 ' A' ' 323' ' ' ILE . 82.9 tt0 -145.13 144.76 31.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.108 -0.995 . . . . 1.45 110.938 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.723 ' O ' HD13 ' A' ' 323' ' ' ILE . 34.1 p90 -117.49 146.87 43.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.212 -0.93 . . . . 0.82999999999999996 110.3 173.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.723 HD13 ' O ' ' A' ' 322' ' ' PHE . 10.5 mm -127.74 137.89 31.7 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.27 -0.894 . . . . 1.3799999999999999 110.392 174.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.559 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 13.0 Cg_exo -62.92 156.5 53.86 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.089 1.573 . . . . 0.26000000000000001 111.112 -178.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 0.749 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -77.18 -166.13 0.67 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.42 -0.8 . . . . 0.16 109.663 172.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.469 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 57.1 tt0 -63.84 104.22 0.66 Allowed 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.279 -0.888 . . . . 0.87 110.387 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 92.64 15.71 51.76 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.389 -1.084 . . . . 0.22 110.389 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.907 HG11 ' O ' ' A' ' 440' ' ' LEU . 57.1 t -104.08 151.28 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.949 -1.324 . . . . 0.20000000000000001 110.693 -177.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -90.06 144.3 26.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.239 -0.913 . . . . 1.8100000000000001 110.309 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.559 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.2 pt-20 -65.08 -39.76 93.68 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.244 -0.91 . . . . 1.77 110.642 -176.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' LYS . . . . . 0.571 ' HA ' ' CZ ' ' A' ' 360' ' ' PHE . 86.9 tttt -60.86 -44.66 96.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.007 -1.058 . . . . 2.4900000000000002 110.278 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 89.1 m -59.03 -45.74 89.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.129 -0.982 . . . . 0.40000000000000002 110.309 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.696 HD11 HD11 ' A' ' 443' ' ' ILE . 20.4 tp -59.99 -45.3 93.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.215 -0.928 . . . . 0.40999999999999998 111.172 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -61.31 -39.24 89.77 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.142 -0.974 . . . . 0.20999999999999999 109.9 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.508 ' OD2' ' NH2' ' A' ' 365' ' ' ARG . 57.5 t0 -65.2 -45.55 84.32 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.053 -1.029 . . . . 1.47 111.337 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.485 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.43 -37.04 85.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.142 -0.974 . . . . 0.20999999999999999 110.309 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.21 -33.71 76.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.055 -1.028 . . . . 0.28999999999999998 110.1 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.676 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -69.63 -52.82 22.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.885 . . . . 1.1200000000000001 111.361 -178.511 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.948 HD12 HG21 ' A' ' 386' ' ' ILE . 0.6 OUTLIER -70.08 -36.08 74.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.69 -1.256 . . . . 0.34999999999999998 110.478 -176.76 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.615 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -67.44 -13.69 62.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.013 -1.055 . . . . 0.20999999999999999 110.309 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.522 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 84.1 p -96.99 -16.57 20.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.27 -0.894 . . . . 0.34999999999999998 110.271 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.565 HD11 ' H ' ' A' ' 365' ' ' ARG . 52.4 mt -58.69 -27.56 64.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.084 -1.01 . . . . 0.20999999999999999 110.023 177.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.526 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.78 -20.98 25.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.3 -0.875 . . . . 0.41999999999999998 110.892 -177.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.511 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.2 p30 -78.2 138.75 38.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.935 -1.103 . . . . 1.22 110.14 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -95.6 6.66 48.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.25 -0.906 . . . . 1.96 110.231 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' THR . . . . . 0.807 HG21 ' CD2' ' A' ' 377' ' ' PHE . 58.6 p -77.6 141.51 65.07 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.294 -0.879 . . . . 0.54000000000000004 110.104 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 346' ' ' THR . 27.2 Cg_exo -57.24 -34.99 98.82 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.991 1.522 . . . . 0.63 110.233 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.563 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 97.2 mt-10 -64.1 -36.01 82.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.916 . . . . 1.4099999999999999 110.121 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.459 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -58.08 -28.69 61.47 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.587 -1.405 . . . . 0.23000000000000001 109.587 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -75.39 -36.02 60.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.896 -1.355 . . . . 2.79 109.438 172.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.75 ' HA ' HD12 ' A' ' 354' ' ' ILE . 17.8 m -54.62 -45.4 73.7 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.293 -0.879 . . . . 1.3 109.861 177.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.628 HG22 ' OE1' ' A' ' 338' ' ' GLN . 10.4 mt -66.86 -47.16 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.061 -1.025 . . . . 0.23000000000000001 110.863 177.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.522 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 73.6 t -54.28 -31.42 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 120.733 -1.229 . . . . 0.31 110.043 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.75 HD12 ' HA ' ' A' ' 351' ' ' SER . 54.5 mt -68.49 -45.81 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.872 -1.143 . . . . 0.31 110.396 169.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 1.109 HD22 ' HB1' ' A' ' 319' ' ' ALA . 63.7 tp -47.26 -53.4 13.48 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.221 -0.924 . . . . 1.28 110.394 -174.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.676 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . -65.19 -36.6 84.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.797 -1.189 . . . . 0.42999999999999999 109.695 175.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 361' ' ' ASN . 7.8 tptp -53.76 -55.03 29.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.866 -1.146 . . . . 2.5099999999999998 110.709 -176.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 14.1 pt20 -66.82 -40.65 88.08 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.585 -1.322 . . . . 1.1899999999999999 109.866 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.462 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 39.7 mmt180 -70.67 -39.81 73.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.35 -0.844 . . . . 2.4399999999999999 111.485 -177.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.792 ' HB3' HD11 ' A' ' 362' ' ' LEU . 99.4 m-85 -116.0 -14.76 11.22 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.791 -1.193 . . . . 1.1200000000000001 110.325 -176.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.535 ' N ' ' O ' ' A' ' 357' ' ' LYS . 44.9 t30 60.39 50.13 6.32 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.764 0.793 . . . . 1.1499999999999999 110.168 -177.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 0.792 HD11 ' HB3' ' A' ' 360' ' ' PHE . 23.2 mt -109.82 176.74 4.95 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.776 -0.578 . . . . 2.3599999999999999 109.815 -177.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -120.84 156.88 31.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.904 -1.122 . . . . 4.1799999999999997 110.967 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -55.52 149.8 13.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.6 -0.687 . . . . 2.1800000000000002 109.729 176.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.565 ' H ' HD11 ' A' ' 342' ' ' LEU . 89.2 mtt180 -98.49 132.85 43.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.034 -1.041 . . . . 2.8500000000000001 110.18 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.486 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.3 m-20 -72.76 114.43 10.88 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.377 -0.827 . . . . 1.8600000000000001 109.908 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.71 HG13 ' HB3' ' A' ' 372' ' ' ALA . 55.6 t -70.56 -44.36 76.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.434 -0.792 . . . . 0.28000000000000003 110.593 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -74.49 -19.2 60.46 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.05 -1.031 . . . . 1.04 111.093 -176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.486 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 60.6 p -74.85 -24.7 58.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.773 -1.204 . . . . 1.27 109.143 171.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.835 HD13 ' CD1' ' A' ' 388' ' ' ILE . 44.3 mt -91.61 3.97 53.77 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.351 -0.843 . . . . 0.38 109.631 171.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.442 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 81.6 m-70 58.17 27.92 15.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.061 -1.025 . . . . 2.5099999999999998 108.746 -171.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.71 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -89.07 -167.12 1.78 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.474 0.654 . . . . 0.26000000000000001 110.308 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 373' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 41.5 m -139.68 143.69 37.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.58 -0.7 . . . . 0.23999999999999999 110.51 -177.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.705 ' CE1' HG21 ' A' ' 367' ' ' VAL . 73.4 m-85 -89.08 142.73 27.38 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.981 -1.074 . . . . 0.23999999999999999 109.596 172.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 1.005 HG11 ' NH1' ' A' ' 394' ' ' ARG . 20.5 t -108.63 112.74 60.46 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.874 -1.141 . . . . 0.17000000000000001 109.835 174.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.7 Cg_endo -54.38 151.6 29.19 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 124.101 1.579 . . . . 0.19 111.378 -175.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.807 ' CD2' HG21 ' A' ' 346' ' ' THR . 1.0 OUTLIER -99.84 122.48 42.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.612 -0.68 . . . . 0.20999999999999999 109.889 178.599 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 27.3 p -109.96 140.28 44.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.16 109.846 176.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.923 ' HB1' ' O2A' ' A' 1001 ' ' ANP . . . -75.85 -30.86 59.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.579 -0.7 . . . . 0.28000000000000003 110.539 -178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -58.2 -44.55 88.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.147 -0.97 . . . . 0.67000000000000004 110.018 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.489 ' O ' ' HG3' ' A' ' 383' ' ' MET . 66.7 m -90.81 -20.32 22.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.195 -0.941 . . . . 1.24 109.786 173.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.517 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 68.6 mtt180 64.82 53.64 1.45 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.558 -0.714 . . . . 2.6800000000000002 109.526 -176.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' MET . . . . . 0.661 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 87.5 mtp -149.76 144.64 26.17 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.055 -1.028 . . . . 1.24 111.299 -176.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.556 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 38.6 p -146.91 170.05 17.87 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.937 -1.135 . . . . 0.14000000000000001 107.937 172.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.448 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -175.74 -165.61 31.97 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 118.652 -1.737 . . . . 0.12 110.31 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.948 HG21 HD12 ' A' ' 339' ' ' LEU . 3.1 tt -151.43 149.92 13.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 O-C-N 121.892 -0.769 . . . . 0.26000000000000001 109.136 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 387' ' ' ASN . . . . . 0.533 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 9.4 m-20 -121.46 144.32 48.75 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.137 -0.977 . . . . 0.37 108.691 176.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.835 ' CD1' HD13 ' A' ' 370' ' ' LEU . 5.5 tt -144.81 164.78 12.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 O-C-N 120.693 -1.255 . . . . 0.51000000000000001 110.165 176.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.73 7.83 0.1 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 113.467 0.914 . . . . 1.1599999999999999 113.467 -172.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.516 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 23.0 t-20 -144.85 2.73 1.05 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.141 -1.599 . . . . 0.95999999999999996 111.366 174.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.528 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 62.9 mtt85 -157.36 159.78 37.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.56 -1.337 . . . . 2.6499999999999999 110.957 -173.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 86.4 mtp -129.89 140.68 50.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.976 -1.077 . . . . 1.8500000000000001 109.074 167.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 0.734 HD13 ' HG2' ' A' ' 435' ' ' GLU . 15.4 mm -130.58 140.93 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.784 -1.198 . . . . 0.16 110.148 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 1.005 ' NH1' HG11 ' A' ' 375' ' ' VAL . 28.5 mmt180 -140.9 141.74 34.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.896 . . . . 1.9399999999999999 110.452 175.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.885 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -143.12 144.48 32.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.405 -0.81 . . . . 0.35999999999999999 109.372 177.507 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.709 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -179.25 -157.15 19.12 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.357 -1.402 . . . . 0.16 110.223 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' SER . . . . . 0.535 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 28.4 m -69.54 155.47 40.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.358 -1.083 . . . . 1.29 110.383 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.929 HG21 ' CG1' ' A' ' 420' ' ' VAL . 87.3 t -59.05 -47.13 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.155 -0.965 . . . . 0.27000000000000002 109.835 -177.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 90.4 m-20 -60.85 -38.7 86.43 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.946 -1.096 . . . . 1.6899999999999999 109.135 172.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 0.661 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -61.11 -49.73 76.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.492 -0.755 . . . . 0.13 110.569 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.709 HD11 ' N ' ' A' ' 396' ' ' GLY . 21.2 mm -66.35 -38.76 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.848 -1.158 . . . . 0.14000000000000001 111.048 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -58.41 -41.94 86.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.862 -1.149 . . . . 2.27 110.106 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 48.9 mtm180 -66.83 -37.65 84.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.07 -1.019 . . . . 3.8399999999999999 110.847 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.522 ' NE2' ' HG3' ' A' ' 394' ' ' ARG . 86.6 t60 -64.17 -40.26 95.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.999 -1.063 . . . . 1.1899999999999999 110.728 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.735 HG13 ' O ' ' A' ' 437' ' ' SER . 97.6 t -64.87 -45.67 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.918 -1.114 . . . . 0.19 110.359 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -62.3 -35.07 77.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.865 -1.147 . . . . 1.4199999999999999 110.839 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.45 -42.22 87.92 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.048 -1.032 . . . . 0.25 109.754 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 98.2 m-20 -67.27 -24.97 65.85 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.374 -0.829 . . . . 1.0900000000000001 109.225 172.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.23 22.89 18.41 Favored Glycine 0 N--CA 1.483 1.776 0 N-CA-C 109.384 -1.486 . . . . 0.26000000000000001 109.384 -176.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.659 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.19 -171.17 41.41 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.458 -1.457 . . . . 0.20999999999999999 109.458 177.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 411' ' ' HIS . . . . . 0.458 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 84.8 t60 -140.29 151.15 44.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.149 -1.206 . . . . 3.1899999999999999 110.205 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.77 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 3.0 t80 -92.02 109.99 41.02 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.16 110.078 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 24.7 Cg_exo -58.51 143.43 98.07 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.87 1.458 . . . . 0.17000000000000001 110.802 -176.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.544 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.4 t -58.95 -43.85 91.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.309 -0.869 . . . . 0.20000000000000001 110.497 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.544 ' N ' ' CG2' ' A' ' 414' ' ' THR . 92.3 m-20 -56.96 -40.37 76.34 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.086 -1.009 . . . . 1.6200000000000001 110.136 -177.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.04 HG11 HG11 ' A' ' 439' ' ' VAL . 53.7 t -68.54 -41.07 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.945 -1.097 . . . . 0.17999999999999999 110.687 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -62.39 -37.7 86.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.965 -1.084 . . . . 2.0 109.987 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.458 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 95.8 mt-30 -64.46 -42.38 95.97 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.202 -0.936 . . . . 2.5600000000000001 110.696 175.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.961 ' O ' HG23 ' A' ' 423' ' ' VAL . 46.3 mttp -63.56 -37.19 86.38 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.745 -1.222 . . . . 1.22 110.79 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 0.929 ' CG1' HG21 ' A' ' 398' ' ' VAL . 24.0 t -63.78 -42.01 94.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.073 -1.017 . . . . 0.23000000000000001 110.303 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 91.9 m-20 -70.46 -42.63 71.21 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.693 -0.629 . . . . 1.1000000000000001 110.863 -177.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.461 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 92.0 mt-30 -65.1 -31.1 72.14 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.337 -0.852 . . . . 1.95 109.691 177.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.961 HG23 ' O ' ' A' ' 419' ' ' LYS . 75.3 t -60.62 -43.91 95.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.094 -1.004 . . . . 0.23000000000000001 109.764 172.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -69.99 -48.76 56.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.372 -0.83 . . . . 0.32000000000000001 110.197 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 83.5 mtp180 -54.56 -22.51 13.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 2.7599999999999998 109.77 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.0 mt-30 -90.31 3.39 53.79 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.384 -0.822 . . . . 2.0499999999999998 110.661 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 86.46 11.94 70.79 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.802 -1.319 . . . . 0.31 109.802 175.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.08 159.36 15.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -1.149 . . . . 0.20000000000000001 109.908 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.1 m -93.21 109.83 42.47 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.884 . . . . 0.20000000000000001 108.853 173.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.62 ' HA ' HG11 ' A' ' 423' ' ' VAL . 3.9 Cg_exo -77.91 112.31 3.25 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 124.042 1.549 . . . . 0.17999999999999999 110.263 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.806 HD21 " O2'" ' A' 1001 ' ' ANP . 73.5 mt -90.07 161.78 15.64 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.812 -1.18 . . . . 0.81999999999999995 108.317 165.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.77 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 68.0 t -124.84 138.14 55.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 120.751 -1.218 . . . . 0.11 110.187 175.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.991 HG12 HD21 ' A' ' 440' ' ' LEU . 22.3 t -117.06 138.05 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.708 -0.62 . . . . 0.17999999999999999 109.637 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.722 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.8 m -127.61 162.71 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.606 -0.684 . . . . 0.31 109.981 178.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.734 ' HG2' HD13 ' A' ' 393' ' ' ILE . 7.8 mt-10 -116.37 123.93 48.8 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.058 -1.026 . . . . 1.23 108.879 166.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.79 -109.86 3.14 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 108.927 -1.669 . . . . 0.29999999999999999 108.927 -171.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.735 ' O ' HG13 ' A' ' 405' ' ' VAL . 25.9 p -119.84 11.16 11.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -1.141 . . . . 0.28999999999999998 110.95 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 438' ' ' ARG . . . . . 0.505 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 30.1 ptt180 -119.71 142.16 48.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.917 -1.114 . . . . 2.1099999999999999 110.164 -177.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 1.04 HG11 HG11 ' A' ' 416' ' ' VAL . 46.0 t -78.93 127.08 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.406 -0.809 . . . . 0.29999999999999999 110.672 -177.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.991 HD21 HG12 ' A' ' 433' ' ' VAL . 0.7 OUTLIER -89.55 -26.06 21.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.34999999999999998 110.718 178.812 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.55 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . -178.8 177.62 48.51 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 119.153 -1.499 . . . . 0.14999999999999999 110.899 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.797 ' O ' HD13 ' A' ' 443' ' ' ILE . 72.2 t -121.42 150.33 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.522 -0.987 . . . . 0.17999999999999999 109.782 178.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.797 HD13 ' O ' ' A' ' 442' ' ' VAL . 11.9 mm -120.89 128.11 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.034 -1.042 . . . . 0.23000000000000001 110.851 -176.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.681 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -100.35 121.64 41.82 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.336 -0.853 . . . . 0.23000000000000001 110.166 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.579 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 5.6 mp -101.25 136.76 40.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.075 -1.016 . . . . 0.26000000000000001 110.354 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -85.62 148.07 26.09 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.363 -0.836 . . . . 1.79 109.617 172.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 447' ' ' ASP . 34.6 p30 -90.53 121.46 32.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 1.6699999999999999 110.494 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 448' ' ' ILE . . . . . 0.583 ' N ' ' CD1' ' A' ' 448' ' ' ILE . 1.1 mp -52.75 -48.08 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.92000000000000004 109.597 177.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.3 t -100.92 134.73 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.504 -0.747 . . . . 1.3300000000000001 110.217 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -145.02 130.66 18.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.261 -0.9 . . . . 3.5 110.134 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.494 -1.442 . . . . 2.52 109.494 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1001 ' ' ANP . . . . . 0.923 ' O2A' ' HB1' ' A' ' 379' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . 0.462 ' HB2' HG12 ' A' ' 448' ' ' ILE . 84.3 m-20 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.273 0.559 . . . . 2.39 110.18 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -123.34 136.76 54.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.245 -0.91 . . . . 2.32 110.301 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.468 ' HA ' ' HB3' ' A' ' 351' ' ' SER . 53.2 tt0 -138.82 140.31 38.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.373 -0.83 . . . . 2.6 110.334 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 1.109 ' HB1' HD22 ' A' ' 355' ' ' LEU . . . -64.72 131.79 47.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.961 -1.087 . . . . 0.31 109.838 175.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.418 ' O ' HD11 ' A' ' 355' ' ' LEU . 1.8 m -110.78 -39.15 4.93 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.172 -0.955 . . . . 0.37 110.333 175.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.461 ' OE2' HD11 ' A' ' 323' ' ' ILE . 82.9 tt0 -145.13 144.76 31.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.108 -0.995 . . . . 1.45 110.938 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.723 ' O ' HD13 ' A' ' 323' ' ' ILE . 34.1 p90 -117.49 146.87 43.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.212 -0.93 . . . . 0.83 110.3 173.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.723 HD13 ' O ' ' A' ' 322' ' ' PHE . 10.5 mm -127.74 137.89 31.7 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.27 -0.894 . . . . 1.38 110.392 174.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.559 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 13.0 Cg_exo -62.92 156.5 53.86 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 124.089 1.573 . . . . 0.26 111.112 -178.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 0.749 ' HB1' ' CG2' ' A' ' 416' ' ' VAL . . . -77.18 -166.13 0.67 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.42 -0.8 . . . . 0.16 109.663 172.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.469 ' HB2' ' HB2' ' A' ' 415' ' ' ASP . 57.1 tt0 -63.84 104.22 0.66 Allowed 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.279 -0.888 . . . . 0.87 110.387 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 92.64 15.71 51.76 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.389 -1.084 . . . . 0.22 110.389 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.907 HG11 ' O ' ' A' ' 440' ' ' LEU . 57.1 t -104.08 151.28 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.949 -1.324 . . . . 0.2 110.693 -177.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -90.06 144.3 26.02 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.239 -0.913 . . . . 1.81 110.309 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.559 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 21.2 pt-20 -65.08 -39.76 93.68 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.244 -0.91 . . . . 1.77 110.642 -176.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . 0.571 ' HA ' ' CZ ' ' A' ' 360' ' ' PHE . 86.9 tttt -60.86 -44.66 96.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.007 -1.058 . . . . 2.49 110.278 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 89.1 m -59.03 -45.74 89.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.129 -0.982 . . . . 0.4 110.309 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.696 HD11 HD11 ' A' ' 443' ' ' ILE . 20.4 tp -59.99 -45.3 93.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.215 -0.928 . . . . 0.41 111.172 -178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -61.31 -39.24 89.77 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.142 -0.974 . . . . 0.21 109.9 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.508 ' OD2' ' NH2' ' A' ' 365' ' ' ARG . 57.5 t0 -65.2 -45.55 84.32 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.053 -1.029 . . . . 1.47 111.337 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.485 ' HA ' HD21 ' A' ' 339' ' ' LEU . . . -65.43 -37.04 85.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.142 -0.974 . . . . 0.21 110.309 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . . . . . . . . . . . -64.21 -33.71 76.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.055 -1.028 . . . . 0.29 110.1 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.676 ' HG3' ' HB3' ' A' ' 356' ' ' ALA . 0.0 OUTLIER -69.63 -52.82 22.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.885 . . . . 1.12 111.361 -178.511 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.948 HD12 HG21 ' A' ' 386' ' ' ILE . 0.6 OUTLIER -70.08 -36.08 74.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.69 -1.256 . . . . 0.35 110.478 -176.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.615 ' HA ' HG22 ' A' ' 386' ' ' ILE . . . -67.44 -13.69 62.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.013 -1.055 . . . . 0.21 110.309 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.522 ' OG ' ' CG2' ' A' ' 353' ' ' VAL . 84.1 p -96.99 -16.57 20.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.27 -0.894 . . . . 0.35 110.271 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.565 HD11 ' H ' ' A' ' 365' ' ' ARG . 52.4 mt -58.69 -27.56 64.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.084 -1.01 . . . . 0.21 110.023 177.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.526 ' CB ' ' HB3' ' A' ' 374' ' ' PHE . . . -87.78 -20.98 25.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.3 -0.875 . . . . 0.42 110.892 -177.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.511 ' OD2' ' HA ' ' A' ' 341' ' ' SER . 1.2 p30 -78.2 138.75 38.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.935 -1.103 . . . . 1.22 110.14 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -95.6 6.66 48.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.25 -0.906 . . . . 1.96 110.231 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . 0.807 HG21 ' CD2' ' A' ' 377' ' ' PHE . 58.6 p -77.6 141.51 65.07 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.294 -0.879 . . . . 0.54 110.104 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 346' ' ' THR . 27.2 Cg_exo -57.24 -34.99 98.82 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.991 1.522 . . . . 0.63 110.233 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.563 ' OE1' ' H8 ' ' A' 1001 ' ' ANP . 97.2 mt-10 -64.1 -36.01 82.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.234 -0.916 . . . . 1.41 110.121 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.459 ' HA3' ' OD1' ' A' ' 344' ' ' ASP . . . -58.08 -28.69 61.47 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.587 -1.405 . . . . 0.23 109.587 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -75.39 -36.02 60.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.896 -1.355 . . . . 2.79 109.438 172.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.75 ' HA ' HD12 ' A' ' 354' ' ' ILE . 17.8 m -54.62 -45.4 73.7 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.293 -0.879 . . . . 1.3 109.861 177.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.628 HG22 ' OE1' ' A' ' 338' ' ' GLN . 10.4 mt -66.86 -47.16 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.061 -1.025 . . . . 0.23 110.863 177.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.522 ' CG2' ' OG ' ' A' ' 341' ' ' SER . 73.6 t -54.28 -31.42 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 120.733 -1.229 . . . . 0.31 110.043 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.75 HD12 ' HA ' ' A' ' 351' ' ' SER . 54.5 mt -68.49 -45.81 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.872 -1.143 . . . . 0.31 110.396 169.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 1.109 HD22 ' HB1' ' A' ' 319' ' ' ALA . 63.7 tp -47.26 -53.4 13.48 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.221 -0.924 . . . . 1.28 110.394 -174.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.676 ' HB3' ' HG3' ' A' ' 338' ' ' GLN . . . -65.19 -36.6 84.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.797 -1.189 . . . . 0.43 109.695 175.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.535 ' O ' ' N ' ' A' ' 361' ' ' ASN . 7.8 tptp -53.76 -55.03 29.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.866 -1.146 . . . . 2.51 110.709 -176.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 355' ' ' LEU . 14.1 pt20 -66.82 -40.65 88.08 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.585 -1.322 . . . . 1.19 109.866 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.462 ' HG2' ' HG3' ' A' ' 358' ' ' GLN . 39.7 mmt180 -70.67 -39.81 73.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.35 -0.844 . . . . 2.44 111.485 -177.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.792 ' HB3' HD11 ' A' ' 362' ' ' LEU . 99.4 m-85 -116.0 -14.76 11.22 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.791 -1.193 . . . . 1.12 110.325 -176.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.535 ' N ' ' O ' ' A' ' 357' ' ' LYS . 44.9 t30 60.39 50.13 6.32 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.764 0.793 . . . . 1.15 110.168 -177.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 0.792 HD11 ' HB3' ' A' ' 360' ' ' PHE . 23.2 mt -109.82 176.74 4.95 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.776 -0.578 . . . . 2.36 109.815 -177.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -120.84 156.88 31.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.904 -1.122 . . . . 4.18 110.967 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -55.52 149.8 13.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.6 -0.687 . . . . 2.18 109.729 176.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.565 ' H ' HD11 ' A' ' 342' ' ' LEU . 89.2 mtt180 -98.49 132.85 43.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.034 -1.041 . . . . 2.85 110.18 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.486 ' HB2' ' OG ' ' A' ' 369' ' ' SER . 92.3 m-20 -72.76 114.43 10.88 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.377 -0.827 . . . . 1.86 109.908 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.71 HG13 ' HB3' ' A' ' 372' ' ' ALA . 55.6 t -70.56 -44.36 76.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.434 -0.792 . . . . 0.28 110.593 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -74.49 -19.2 60.46 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.05 -1.031 . . . . 1.04 111.093 -176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.486 ' OG ' ' HB2' ' A' ' 366' ' ' ASP . 60.6 p -74.85 -24.7 58.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.773 -1.204 . . . . 1.27 109.143 171.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.835 HD13 ' CD1' ' A' ' 388' ' ' ILE . 44.3 mt -91.61 3.97 53.77 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.351 -0.843 . . . . 0.38 109.631 171.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.442 ' HB2' ' O ' ' A' ' 370' ' ' LEU . 81.6 m-70 58.17 27.92 15.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.061 -1.025 . . . . 2.51 108.746 -171.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.71 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -89.07 -167.12 1.78 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.474 0.654 . . . . 0.26 110.308 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' A' ' 387' ' ' ASN . 41.5 m -139.68 143.69 37.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.58 -0.7 . . . . 0.24 110.51 -177.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.705 ' CE1' HG21 ' A' ' 367' ' ' VAL . 73.4 m-85 -89.08 142.73 27.38 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.981 -1.074 . . . . 0.24 109.596 172.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 1.005 HG11 ' NH1' ' A' ' 394' ' ' ARG . 20.5 t -108.63 112.74 60.46 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.874 -1.141 . . . . 0.17 109.835 174.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 8.7 Cg_endo -54.38 151.6 29.19 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 124.101 1.579 . . . . 0.19 111.378 -175.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.807 ' CD2' HG21 ' A' ' 346' ' ' THR . 1.0 OUTLIER -99.84 122.48 42.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.612 -0.68 . . . . 0.21 109.889 178.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 27.3 p -109.96 140.28 44.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.16 109.846 176.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.923 ' HB1' ' O2A' ' A' 1001 ' ' ANP . . . -75.85 -30.86 59.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.579 -0.7 . . . . 0.28 110.539 -178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -58.2 -44.55 88.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.147 -0.97 . . . . 0.67 110.018 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.489 ' O ' ' HG3' ' A' ' 383' ' ' MET . 66.7 m -90.81 -20.32 22.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.195 -0.941 . . . . 1.24 109.786 173.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.517 ' CB ' ' OG ' ' A' ' 397' ' ' SER . 68.6 mtt180 64.82 53.64 1.45 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.558 -0.714 . . . . 2.68 109.526 -176.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 0.661 ' CG ' ' HB1' ' A' ' 400' ' ' ALA . 87.5 mtp -149.76 144.64 26.17 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.055 -1.028 . . . . 1.24 111.299 -176.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.556 ' HB3' ' CG ' ' A' ' 377' ' ' PHE . 38.6 p -146.91 170.05 17.87 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.937 -1.135 . . . . 0.14 107.937 172.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.448 ' C ' ' HB ' ' A' ' 375' ' ' VAL . . . -175.74 -165.61 31.97 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 118.652 -1.737 . . . . 0.12 110.31 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.948 HG21 HD12 ' A' ' 339' ' ' LEU . 3.1 tt -151.43 149.92 13.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 O-C-N 121.892 -0.769 . . . . 0.26 109.136 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.533 ' O ' ' HB1' ' A' ' 372' ' ' ALA . 3.0 m120 -121.46 144.32 48.75 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 121.137 -0.977 . . . . 0.37 108.691 176.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.835 ' CD1' HD13 ' A' ' 370' ' ' LEU . 5.5 tt -144.81 164.78 12.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 O-C-N 120.693 -1.255 . . . . 0.51 110.165 176.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.73 7.83 0.1 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 113.467 0.914 . . . . 1.16 113.467 -172.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.516 ' O ' ' CG ' ' A' ' 391' ' ' ARG . 23.0 t-20 -144.85 2.73 1.05 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.141 -1.599 . . . . 0.96 111.366 174.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.528 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 62.9 mtt85 -157.36 159.78 37.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.56 -1.337 . . . . 2.65 110.957 -173.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 86.4 mtp -129.89 140.68 50.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.976 -1.077 . . . . 1.85 109.074 167.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 0.734 HD13 ' HG2' ' A' ' 435' ' ' GLU . 15.4 mm -130.58 140.93 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.784 -1.198 . . . . 0.16 110.148 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 1.005 ' NH1' HG11 ' A' ' 375' ' ' VAL . 28.5 mmt180 -140.9 141.74 34.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.896 . . . . 1.94 110.452 175.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.885 ' CG ' HG22 ' A' ' 433' ' ' VAL . 0.1 OUTLIER -143.12 144.48 32.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.405 -0.81 . . . . 0.36 109.372 177.507 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.709 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -179.25 -157.15 19.12 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.357 -1.402 . . . . 0.16 110.223 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . 0.535 ' O ' ' HB3' ' A' ' 400' ' ' ALA . 28.4 m -69.54 155.47 40.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.358 -1.083 . . . . 1.29 110.383 -178.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.929 HG21 ' CG1' ' A' ' 420' ' ' VAL . 87.3 t -59.05 -47.13 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.155 -0.965 . . . . 0.27 109.835 -177.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 90.4 m-20 -60.85 -38.7 86.43 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.946 -1.096 . . . . 1.69 109.135 172.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 0.661 ' HB1' ' CG ' ' A' ' 383' ' ' MET . . . -61.11 -49.73 76.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.492 -0.755 . . . . 0.13 110.569 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.709 HD11 ' N ' ' A' ' 396' ' ' GLY . 21.2 mm -66.35 -38.76 82.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.848 -1.158 . . . . 0.14 111.048 -178.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -58.41 -41.94 86.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.862 -1.149 . . . . 2.27 110.106 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 48.9 mtm180 -66.83 -37.65 84.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.07 -1.019 . . . . 3.84 110.847 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.522 ' NE2' ' HG3' ' A' ' 394' ' ' ARG . 86.6 t60 -64.17 -40.26 95.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.999 -1.063 . . . . 1.19 110.728 177.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.735 HG13 ' O ' ' A' ' 437' ' ' SER . 97.6 t -64.87 -45.67 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.918 -1.114 . . . . 0.19 110.359 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -62.3 -35.07 77.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.865 -1.147 . . . . 1.42 110.839 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -66.45 -42.22 87.92 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.048 -1.032 . . . . 0.25 109.754 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 437' ' ' SER . 98.2 m-20 -67.27 -24.97 65.85 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.374 -0.829 . . . . 1.09 109.225 172.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 96.23 22.89 18.41 Favored Glycine 0 N--CA 1.483 1.776 0 N-CA-C 109.384 -1.486 . . . . 0.26 109.384 -176.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.659 ' C ' HG12 ' A' ' 405' ' ' VAL . . . -92.19 -171.17 41.41 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.458 -1.457 . . . . 0.21 109.458 177.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . 0.458 ' O ' ' HD3' ' A' ' 413' ' ' PRO . 84.8 t60 -140.29 151.15 44.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.149 -1.206 . . . . 3.19 110.205 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.77 ' CZ ' HG11 ' A' ' 432' ' ' VAL . 3.0 t80 -92.02 109.99 41.02 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.16 110.078 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 411' ' ' HIS . 24.7 Cg_exo -58.51 143.43 98.07 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.87 1.458 . . . . 0.17 110.802 -176.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.544 ' CG2' ' N ' ' A' ' 415' ' ' ASP . 5.4 t -58.95 -43.85 91.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.309 -0.869 . . . . 0.2 110.497 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.544 ' N ' ' CG2' ' A' ' 414' ' ' THR . 92.3 m-20 -56.96 -40.37 76.34 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.086 -1.009 . . . . 1.62 110.136 -177.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.04 HG11 HG11 ' A' ' 439' ' ' VAL . 53.7 t -68.54 -41.07 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.945 -1.097 . . . . 0.18 110.687 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -62.39 -37.7 86.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.965 -1.084 . . . . 2.0 109.987 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.458 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 95.8 mt-30 -64.46 -42.38 95.97 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.202 -0.936 . . . . 2.56 110.696 175.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.961 ' O ' HG23 ' A' ' 423' ' ' VAL . 46.3 mttp -63.56 -37.19 86.38 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.745 -1.222 . . . . 1.22 110.79 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 0.929 ' CG1' HG21 ' A' ' 398' ' ' VAL . 24.0 t -63.78 -42.01 94.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.073 -1.017 . . . . 0.23 110.303 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 425' ' ' ARG . 91.9 m-20 -70.46 -42.63 71.21 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.693 -0.629 . . . . 1.1 110.863 -177.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.461 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 92.0 mt-30 -65.1 -31.1 72.14 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.337 -0.852 . . . . 1.95 109.691 177.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.961 HG23 ' O ' ' A' ' 419' ' ' LYS . 75.3 t -60.62 -43.91 95.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.094 -1.004 . . . . 0.23 109.764 172.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -69.99 -48.76 56.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.372 -0.83 . . . . 0.32 110.197 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 421' ' ' ASP . 83.5 mtp180 -54.56 -22.51 13.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 2.76 109.77 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 422' ' ' GLN . 96.0 mt-30 -90.31 3.39 53.79 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.384 -0.822 . . . . 2.05 110.661 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 86.46 11.94 70.79 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.802 -1.319 . . . . 0.31 109.802 175.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.468 ' O ' ' HD3' ' A' ' 430' ' ' PRO . . . -104.08 159.36 15.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -1.149 . . . . 0.2 109.908 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.1 m -93.21 109.83 42.47 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.285 -0.884 . . . . 0.2 108.853 173.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.62 ' HA ' HG11 ' A' ' 423' ' ' VAL . 3.9 Cg_exo -77.91 112.31 3.25 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 O-C-N 124.042 1.549 . . . . 0.18 110.263 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.806 HD21 " O2'" ' A' 1001 ' ' ANP . 73.5 mt -90.07 161.78 15.64 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.812 -1.18 . . . . 0.82 108.317 165.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.77 HG11 ' CZ ' ' A' ' 412' ' ' PHE . 68.0 t -124.84 138.14 55.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 120.751 -1.218 . . . . 0.11 110.187 175.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.991 HG12 HD21 ' A' ' 440' ' ' LEU . 22.3 t -117.06 138.05 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.708 -0.62 . . . . 0.18 109.637 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.722 ' C ' HD23 ' A' ' 440' ' ' LEU . 2.8 m -127.61 162.71 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.606 -0.684 . . . . 0.31 109.981 178.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.734 ' HG2' HD13 ' A' ' 393' ' ' ILE . 7.8 mt-10 -116.37 123.93 48.8 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.058 -1.026 . . . . 1.23 108.879 166.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.79 -109.86 3.14 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 108.927 -1.669 . . . . 0.3 108.927 -171.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.735 ' O ' HG13 ' A' ' 405' ' ' VAL . 25.9 p -119.84 11.16 11.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -1.141 . . . . 0.29 110.95 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . 0.505 ' O ' ' HB ' ' A' ' 434' ' ' VAL . 30.1 ptt180 -119.71 142.16 48.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.917 -1.114 . . . . 2.11 110.164 -177.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 1.04 HG11 HG11 ' A' ' 416' ' ' VAL . 46.0 t -78.93 127.08 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.406 -0.809 . . . . 0.3 110.672 -177.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.991 HD21 HG12 ' A' ' 433' ' ' VAL . 0.7 OUTLIER -89.55 -26.06 21.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.35 110.718 178.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.55 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . -178.8 177.62 48.51 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 119.153 -1.499 . . . . 0.15 110.899 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.797 ' O ' HD13 ' A' ' 443' ' ' ILE . 72.2 t -121.42 150.33 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.522 -0.987 . . . . 0.18 109.782 178.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.797 HD13 ' O ' ' A' ' 442' ' ' VAL . 11.9 mm -120.89 128.11 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.034 -1.042 . . . . 0.23 110.851 -176.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.681 ' CB ' HG13 ' A' ' 423' ' ' VAL . . . -100.35 121.64 41.82 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.336 -0.853 . . . . 0.23 110.166 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.579 ' CD1' ' N ' ' A' ' 445' ' ' LEU . 5.6 mp -101.25 136.76 40.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.075 -1.016 . . . . 0.26 110.354 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -85.62 148.07 26.09 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.363 -0.836 . . . . 1.79 109.617 172.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 447' ' ' ASP . 34.6 p30 -90.53 121.46 32.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.18 -0.95 . . . . 1.67 110.494 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . 0.583 ' CD1' ' N ' ' A' ' 448' ' ' ILE . 1.1 mp -52.75 -48.08 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.92 109.597 177.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 46.3 t -100.92 134.73 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.504 -0.747 . . . . 1.33 110.217 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -145.02 130.66 18.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.261 -0.9 . . . . 3.5 110.134 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.494 -1.442 . . . . 2.52 109.494 179.991 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1001 ' ' ANP . . . . . 0.923 ' O2A' ' HB1' ' A' ' 379' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_